Institutional Ownership
Biogen Inc
CUSIP 09062X103COMBIIBQ1 2026
Latest EPS (Diluted)
$2.15
Q1 2026 · Mar 31, 2026
Latest Revenue
$2.48B
Reported quarter
Latest Net Income
$319.50M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $2.17 | $2.15 | $2.48B | $319.50M | 10-Q |
| Sep 30, 2025 | Q3 2025 | $3.18 | $3.17 | $2.53B | $466.50M | 10-Q |
| Jun 30, 2025 | Q2 2025 | $4.33 | $4.33 | $2.65B | $634.80M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $1.65 | $1.64 | $2.43B | $240.50M | 10-Q |
| Sep 30, 2024 | Q3 2024 | $2.67 | $2.66 | $2.47B | $388.50M | 10-Q |
| Jun 30, 2024 | Q2 2024 | $4.01 | $4.00 | $2.46B | $583.60M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $2.71 | $2.70 | $2.29B | $393.40M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $-0.47 | $-0.47 | $2.53B | -$68.10M | 10-Q |
| Jun 30, 2023 | Q2 2023 | $4.09 | $4.07 | $2.46B | $591.60M | 10-Q |
| Mar 31, 2023 | Q1 2023 | $2.69 | $2.67 | $2.46B | $387.90M | 10-Q |
| Sep 30, 2022 | Q3 2022 | $7.86 | $7.84 | $2.51B | $1.13B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $7.25 | $7.24 | $2.59B | $1.06B | 10-Q |